These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
199 related articles for article (PubMed ID: 2671238)
1. Metformin treatment of lean and obese Zucker rats modulates the ability of glucagon and insulin to regulate hepatocyte adenylate cyclase activity. Gawler DJ; Wilson A; Houslay MD J Endocrinol; 1989 Jul; 122(1):207-12. PubMed ID: 2671238 [TBL] [Abstract][Full Text] [Related]
2. Multiple defects occur in the guanine nucleotide regulatory protein system in liver plasma membranes of obese (fa/fa) but not lean (Fa/Fa) Zucker rats: loss of functional Gi and abnormal Gs function. Houslay MD; Gawler DJ; Milligan G; Wilson A Cell Signal; 1989; 1(1):9-22. PubMed ID: 2561940 [TBL] [Abstract][Full Text] [Related]
3. Treatment of streptozotocin-diabetic rats with metformin restores the ability of insulin to inhibit adenylate cyclase activity and demonstrates that insulin does not exert this action through the inhibitory guanine nucleotide regulatory protein Gi. Gawler D; Milligan G; Houslay MD Biochem J; 1988 Jan; 249(2):537-42. PubMed ID: 3124829 [TBL] [Abstract][Full Text] [Related]
4. Impairment of hormone-stimulated cardiac adenylate cyclase activity in the genetically obese (fa/fa) Zucker rat. Chatelain P; Robberecht P; De Neef P; Camus JC; Poloczek P; Christophe J Pflugers Arch; 1981 Apr; 390(1):10-6. PubMed ID: 6264381 [TBL] [Abstract][Full Text] [Related]
5. Alterations in G-protein expression and the hormonal regulation of adenylate cyclase in the adipocytes of obese (fa/fa) Zucker rats. Strassheim D; Palmer T; Milligan G; Houslay MD Biochem J; 1991 May; 276 ( Pt 1)(Pt 1):197-202. PubMed ID: 1903933 [TBL] [Abstract][Full Text] [Related]
6. Nonreceptor-mediated responses of adenylate cyclase in membranes from liver, muscle, and white and brown adipose tissue of obese (fa/fa) and lean (Fa/) Zucker rats. Naim M; Katz Y; Brand JG; Kare MR Proc Soc Exp Biol Med; 1990 Dec; 195(3):369-74. PubMed ID: 2175438 [TBL] [Abstract][Full Text] [Related]
7. Changes in the phosphorylation state of the inhibitory guanine-nucleotide-binding protein Gi-2 in hepatocytes from lean (Fa/Fa) and obese (fa/fa) Zucker rats. Bushfield M; Pyne NJ; Houslay MD Eur J Biochem; 1990 Sep; 192(2):537-42. PubMed ID: 2120055 [TBL] [Abstract][Full Text] [Related]
8. The regulation of adenylate cyclase in liver membranes of lean and obese mice. Bégin-Heick N; Welsh J Mol Cell Endocrinol; 1988 Oct; 59(3):187-94. PubMed ID: 3181621 [TBL] [Abstract][Full Text] [Related]
9. Determination of G-protein levels, ADP-ribosylation by cholera and pertussis toxins and the regulation of adenylyl cyclase activity in liver plasma membranes from lean and genetically diabetic (db/db) mice. Palmer TM; Houslay MD Biochim Biophys Acta; 1991 Oct; 1097(3):193-204. PubMed ID: 1932144 [TBL] [Abstract][Full Text] [Related]
10. The activity of glucagon-stimulated adenylate cyclase from rat liver plasma membranes is modulated by the fluidity of its lipid environment. Dipple I; Houslay MD Biochem J; 1978 Jul; 174(1):179-90. PubMed ID: 697751 [TBL] [Abstract][Full Text] [Related]
11. Liver membrane adenylate cyclase. Synergistic effects of anions on fluoride, glucagon, and guanyl nucleotide stimulation. Johnson RA; Pilkis SJ; Hamet P J Biol Chem; 1975 Aug; 250(16):6599-607. PubMed ID: 125755 [TBL] [Abstract][Full Text] [Related]
12. Involvement of calcium in the inhibition by insulin of the glucagon-stimulated adenylate-cyclase activity. Kiss Z Eur J Biochem; 1979 Apr; 95(3):607-11. PubMed ID: 446485 [TBL] [Abstract][Full Text] [Related]
13. Insulin and glucagon attenuate the ability of cholera toxin to activate adenylate cyclase in intact hepatocytes. Irvine FJ; Houslay MD Biochem J; 1988 Apr; 251(2):447-52. PubMed ID: 2840894 [TBL] [Abstract][Full Text] [Related]
14. Inhibition of the glucagon stimulated adenylate cyclase activity by insulin. Kiss Z FEBS Lett; 1978 Aug; 92(1):29-32. PubMed ID: 668918 [No Abstract] [Full Text] [Related]
15. Modulation of adenylate cyclase activity in liver and fat cell membranes by insulin. Illiano G; Cuatrecasas P Science; 1972 Feb; 175(4024):906-8. PubMed ID: 4332823 [TBL] [Abstract][Full Text] [Related]
16. N6-(Phenylisopropyl)adenosine prevents glucagon both blocking insulin's activation of the plasma-membrane cyclic AMP phosphodiesterase and uncoupling hormonal stimulation of adenylate cyclase activity in hepatocytes. Wallace AV; Heyworth CM; Houslay MD Biochem J; 1984 Aug; 222(1):177-82. PubMed ID: 6089755 [TBL] [Abstract][Full Text] [Related]
17. The adenylate cyclase system in human liver: characterization, subcellular distribution and hormonal sensitivity in normal or cirrhotic adult, and in foetal liver. Pecker F; Duvaldestin P; Berthelot P; Hanoune J Clin Sci (Lond); 1979 Oct; 57(4):313-25. PubMed ID: 41665 [TBL] [Abstract][Full Text] [Related]
18. Adenylate cyclase and insulin action. Effect of insulin, nonsuppressible insulin-like material, and diabetes on adenylate-cyclase activity in mouse liver. Hepp KD Eur J Biochem; 1972 Dec; 31(2):266-76. PubMed ID: 4345916 [No Abstract] [Full Text] [Related]
19. Adenylate cyclase of catfish hepatocyte membranes: basal properties and sensitivity to catecholamines and glucagon. Ottolenghi C; Fabbri E; Puviani AC; Gavioli ME; Brighenti L Mol Cell Endocrinol; 1988 Dec; 60(2-3):163-8. PubMed ID: 2850955 [TBL] [Abstract][Full Text] [Related]